ARFI: a new non-invasive method for evaluation of liver fibrosis

  • Takaki Shintaro
    Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University
  • Kawakami Yoshiiku
    Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University
  • Azagami Takahiro
    Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University
  • Kimura Yuki
    Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University
  • Yokoyama Satoe
    Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University
  • Katamura Yoshio
    Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University
  • Kawaoka Tomokazu
    Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University
  • Sanetoh Hiromi
    Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University
  • Ishitobi Tomokazu
    Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University
  • Tsuge Masataka
    Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University
  • Hiramatsu Akira
    Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University
  • Waki Koji
    Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University
  • Imamura Michio
    Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University
  • Hyogo Hideyuki
    Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University
  • Aikata Hiroshi
    Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University
  • Takahashi Shoichi
    Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University
  • Chayama Kazuaki
    Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University

Bibliographic Information

Other Title
  • ARFI(Acoustic Radiation Force Impulse):新しい非侵襲的方法による肝線維化の評価
  • ARFI Acoustic Radiation Force Impulse アタラシイ ヒシンシュウテキ ホウホウ ニ ヨル カン センイカ ノ ヒョウカ

Search this article

Description

We evaluate the Acoustic Radiation Force Impulse (ARFI) for the non-invasive assessment of liver fibrosis in chronic liver disease patients, compared with transient electrography (FibroScan®502). Liver stiffness values measured by FibroScan®502 correlates well with liver fibrosis stage (F0-1: 5.5 Kpa, F2: 8.6 Kpa, F3: 10.5 Kpa, F4: 17.8 Kpa). In addition, liver stiffness quantification by ARFI is very well correlated with liver stiffness values by FibroScan®502 (r=0.88, P<0.001). ARFI is considered a new useful tool for assessment of the liver fibrosis with non-invasive methods.<br>

Journal

  • Kanzo

    Kanzo 50 (8), 467-469, 2009

    The Japan Society of Hepatology

References(4)*help

See more

Details 詳細情報について

Report a problem

Back to top